Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(18/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(18/week)
News
United States
(584/week)
Manufacturing
(404/week)
Energy
(324/week)
Technology
(409/week)
Other Manufacturing
(344/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Medicenna Therapeutics Corp.
Jun 11, 2020
Medicenna to Present at Raymond James Human Healthcare Innovation Conference
May 29, 2020
Medicenna Presents Data on MDNA11, an IL-2 Superkine at ASCO 2020
May 29, 2020
Medicenna Updates Efficacy Results from Phase 2b Recurrent GBM Trial at ASCO 2020
May 15, 2020
Medicenna Announces March 31, 2020 Year-End Results
May 04, 2020
Medicenna Announces Upcoming Presentations at the ASCO Annual Meeting
Mar 25, 2020
Medicenna's IL-2 Superkine, MDNA19, Demonstrates Best-in-Class Features in a Non-Human Primate Study
Feb 13, 2020
Medicenna Reports Third Quarter Fiscal 2020 Financial Results
Jan 13, 2020
Medicenna Reports Compelling Results from Recurrent Glioblastoma Trial When Compared to an Eligibility-Matched Control Arm
Jan 08, 2020
Medicenna Receives $1.3 Million Through Early Warrant Exercises
Dec 12, 2019
Medicenna Presents Additional Encouraging Phase 2b Clinical Data at the Inaugural Glioblastoma Drug Development Annual Summit
Dec 09, 2019
Medicenna Announces Presentation of the MDNA55 Clinical Trial at the Inaugural Glioblastoma Drug Development Annual Summit
Nov 25, 2019
Medicenna Reports Promising Efficacy in Phase 2b MDNA55 Clinical Trial at the Society for Neuro-Oncology Annual Meeting
Nov 21, 2019
Medicenna Reports Improved Drug Distribution of MDNA55 with Novel Delivery Technology in Phase 2b Recurrent Glioblastoma Clinical Trial
Nov 20, 2019
Medicenna To Host Key Opinion Leader Call Focused on Latest MDNA55 Recurrent Glioblastoma Phase 2b Clinical Study Results
Nov 18, 2019
Medicenna to Host a Key Opinion Leader Symposium on MDNA55 for Treatment of Recurrent Glioblastoma
Nov 14, 2019
Medicenna Announces Presentations on MDNA55 Recurrent Glioblastoma Clinical Trial at the Annual Meeting of the Society of Neuro-Oncology
Sep 30, 2019
Medicenna Presented Promising Preclinical Results from its IL-2 Superkine Platform at the 5th Annual International Cancer Immunotherapy Conference
Sep 26, 2019
Nature Communications Publishes Studies on Medicenna's IL-2 Superkine Platform
Sep 25, 2019
Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress
Sep 24, 2019
Medicenna Strengthens Board of Directors by Appointment of Seasoned Biopharma Executive Ms. Karen Dawes
Page 1
››
Latest News
May 14, 2024
Middle Tennessee Electric and Silicon Ranch Announce First Utility-Scale Solar Project Under TVA’s Expanded...
May 14, 2024
USAA to Gift Vehicle to Military Family in the Chicago Area
May 14, 2024
Balfour Beatty Substantially Completes Caltrain Electrification
May 14, 2024
Customers Save $9 Billion in Energy Costs Through Award-Winning ComEd Energy Efficiency Program
May 14, 2024
Bilateral Chamber's Key Events Focusing on Energy, Geopolitics, and Investment Opportunities in Pivotal...
May 14, 2024
Heritage Global Partners and Integra Asset Solutions Host Exclusive Online Auction Featuring Furniture...
May 14, 2024
Traka ASSA ABLOY Americas Awarded GSA Contract for Electronic Key Management Solutions
May 14, 2024
Comvest Partners’ Portfolio Company GAI Consultants Announces Acquisition of Creighton Manning Engineering
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events